Tasly Microcirculation Research Center, Peking University Health Science Center, Beijing, China.
J Ethnopharmacol. 2010 Jul 20;130(2):398-406. doi: 10.1016/j.jep.2010.05.030. Epub 2010 May 24.
Cerebralcare Granule (CG) is a Chinese herb compound preparation that has been used for treatment of cerebrovascular related diseases. However, the effect of post-treatment with CG on ischemia and reperfusion (I/R) induced cerebral injury is so far unclear.
In present study, cerebral global I/R was induced in Mongolian gerbils by clamping bilateral carotid arteries for 30 min followed by reperfusion for 5 days, and CG (0.4 g/kg or 0.8 g/kg) was administrated 3h after the initiation of reperfusion.
Post-treatment with CG for 5 days attenuated the I/R-induced production of hydrogen peroxide in, leukocyte adhesion to, and albumin leakage from cerebral microvessels, and, meanwhile, protected neuron from death, reduced the number of caspase-3- and Bax-positive cells, and increased Bcl-2-positive cells in hippocampal CA1 region.
The results suggest that CG given after initiation of reperfusion is able to ameliorate cerebral microvascular dysfunction and hippocampal CA1 neuron damage caused by I/R.
脑心泰颗粒(CG)是一种中药复方制剂,用于治疗脑血管相关疾病。然而,迄今为止,尚不清楚 CG 对缺血再灌注(I/R)引起的脑损伤的治疗后作用。
本研究采用夹闭双侧颈总动脉 30min 再灌注 5d 的方法制备蒙古沙土鼠全脑 I/R 模型,在再灌注开始后 3h 给予 CG(0.4g/kg 或 0.8g/kg)。
CG 治疗 5d 可减轻 I/R 诱导的脑微血管中过氧化氢的产生、白细胞黏附和白蛋白漏出,同时保护神经元免受死亡,减少海马 CA1 区 caspase-3 和 Bax 阳性细胞的数量,增加 Bcl-2 阳性细胞的数量。
这些结果表明,再灌注开始后给予 CG 可改善 I/R 引起的脑微血管功能障碍和海马 CA1 神经元损伤。